| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SDZ.SW - | HOLD | 0 @ CHF 62.3762 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 62.3762. The average price that SDZ.SW shares were previous bought at was CHF 44.4138. The current market price is 40.4% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 164,446 (USD $206,798) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 120.1 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 120.1. The average price that IPN.PA shares were previous bought at was EUR 103.946. The current market price is 15.5% higher than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 569.419 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 569.419. The average price that LONN.SW shares were previous bought at was CHF 606.222. The current market price is -6.1% lower than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 257,151 (USD $323,379) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 118.85 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 118.85. The average price that MRK.DE shares were previous bought at was EUR 115.921. The current market price is 2.5% higher than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 27,614 (USD $32,425) compared to the previous valuation of Merck KGaA |
| NOVN.SW - | HOLD | 0 @ CHF 115.71 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 115.71. The average price that NOVN.SW shares were previous bought at was CHF 101.538. The current market price is 14.0% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 94,493 (USD $118,829) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 40.7293 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 40.7293. The average price that NOVO-B.CO shares were previous bought at was DKK 62.9092. The current market price is -35.3% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 703,017 (USD $110,500) compared to the previous valuation of Novo Nordisk A/S |
| NSIS-B.CO - | HOLD | 0 @ DKK 54.0738 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 54.0738. The average price that NSIS-B.CO shares were previous bought at was DKK 60.9297. The current market price is -11.3% lower than average price they were purchased at. The value of the holding in NSIS-B.CO has increased by DKK 220,042 (USD $34,586) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 61.3 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 61.3. The average price that ORNBV.HE shares were previous bought at was EUR 60.1949. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 27,798 (USD $32,641) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 22.79 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 22.79. The average price that PHIA.AS shares were previous bought at was EUR 21.0698. The current market price is 8.2% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 143,420 (USD $168,408) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 38.445 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 38.445. The average price that QIA.DE shares were previous bought at was EUR 42.5059. The current market price is -9.6% lower than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 3,253 (USD $3,820) compared to the previous valuation of QIAGEN NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 48.56 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 48.56. The average price that REC.MI shares were previous bought at was EUR 53.4006. The current market price is -9.1% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 4,719 (USD $5,541) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 343.134 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 343.134. The average price that ROG.SW shares were previous bought at was CHF 282.272. The current market price is 21.6% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 1,082,444 (USD $1,361,222) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 82.1 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 82.1. The average price that SAN.PA shares were previous bought at was EUR 88.9071. The current market price is -7.7% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 9,722 (USD $11,416) compared to the previous valuation of Sanofi SA |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.23053 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.23053. The average price that HLN.L shares were previous bought at was GBP 4.56169. The current market price is -7.3% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 79,376 (USD $106,162) compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SECT-B.ST - | HOLD | 0 @ SEK 23.1954 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 23.1954. The average price that SECT-B.ST shares were previous bought at was SEK 28.9777. The current market price is -20.0% lower than average price they were purchased at. The value of the holding in SECT-B.ST has increased by SEK 16,350 (USD $1,758) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SFZN.SW - | HOLD | 0 @ CHF 80.1182 | CHF 0 | The current share valuation price of SFZN.SW based on adjusted close was CHF 80.1182. The average price that SFZN.SW shares were previous bought at was CHF 105.062. The current market price is -23.7% lower than average price they were purchased at. The value of the holding in SFZN.SW has increased by CHF 54,662 (USD $68,740) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 44.72 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 44.72. The average price that SHL.DE shares were previous bought at was EUR 47.8674. The current market price is -6.6% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 11,139 (USD $13,080) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.0542 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.0542. The average price that SN.L shares were previous bought at was GBP 12.7777. The current market price is 10.0% higher than average price they were purchased at. The value of the holding in SN.L has increased by GBP 42,232 (USD $56,484) compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 29.7702 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 29.7702. The average price that SOBI.ST shares were previous bought at was SEK 26.5488. The current market price is 12.1% higher than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 10,383 (USD $1,117) compared to the previous valuation of |
| SOON.SW - | HOLD | 0 @ CHF 221.775 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 221.775. The average price that SOON.SW shares were previous bought at was CHF 270.717. The current market price is -18.1% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 27,667 (USD $34,793) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 237.5 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 237.5. The average price that SRT3.DE shares were previous bought at was EUR 215.854. The current market price is 10.0% higher than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 10,698 (USD $12,562) compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 101.404 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 101.404. The average price that STMN.SW shares were previous bought at was CHF 113.444. The current market price is -10.6% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 5,033 (USD $6,329) compared to the previous valuation of |
| TECN.SW - | HOLD | 0 @ CHF 136.287 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 136.287. The average price that TECN.SW shares were previous bought at was CHF 178.017. The current market price is -23.4% lower than average price they were purchased at. The value of the holding in TECN.SW has increased by CHF 21,039 (USD $26,457) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 209.5 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 209.5. The average price that TUB.BR shares were previous bought at was EUR 129.729. The current market price is 61.5% higher than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 236.4 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 236.4. The average price that UCB.BR shares were previous bought at was EUR 163.958. The current market price is 44.2% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 68,784 (USD $80,768) compared to the previous valuation of UCB SA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 62.4124 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 62.4124. The average price that ZEAL.CO shares were previous bought at was DKK 59.0991. The current market price is 5.6% higher than average price they were purchased at. The value of the holding in ZEAL.CO has increased by DKK 15,850 (USD $2,491) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 28.4824 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 28.4824. The average price that DEMANT.CO shares were previous bought at was DKK 35.4935. The current market price is -19.8% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 9,268 (USD $1,457) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 68.3905 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 68.3905. The average price that ALC.SW shares were previous bought at was CHF 77.5313. The current market price is -11.8% lower than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 117,282 (USD $147,487) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ALK-B.CO - | HOLD | 0 @ DKK 30.2224 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 30.2224. The average price that ALK-B.CO shares were previous bought at was DKK 23.714. The current market price is 27.4% higher than average price they were purchased at. The value of the holding in ALK-B.CO has increased by DKK 21,393 (USD $3,363) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| AMBU-B.CO - | HOLD | 0 @ DKK 11.6379 | DKK 0 | The current share valuation price of AMBU-B.CO based on adjusted close was DKK 11.6379. The average price that AMBU-B.CO shares were previous bought at was DKK 13.8347. The current market price is -15.9% lower than average price they were purchased at. The value of the holding in AMBU-B.CO has fallen by DKK 977 (USD $154) compared to the previous valuation of |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 13.775 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 13.775. The average price that AMP.MI shares were previous bought at was EUR 20.1651. The current market price is -31.7% lower than average price they were purchased at. The value of the holding in AMP.MI has fallen by EUR 7,243 (USD $8,505) compared to the previous valuation of Amplifon SpA |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 728 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 728. The average price that ARGX.BR shares were previous bought at was EUR 512.287. The current market price is 42.1% higher than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 438,866 (USD $515,331) compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 154.739 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 154.739. The average price that AZN.L shares were previous bought at was GBP 125.529. The current market price is 23.3% higher than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 152,391 (USD $203,817) compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| BAVA.CO - | HOLD | 0 @ DKK 25.163 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 25.163. The average price that BAVA.CO shares were previous bought at was DKK 22.9348. The current market price is 9.7% higher than average price they were purchased at. The value of the holding in BAVA.CO has increased by DKK 19,693 (USD $3,095) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 35.3 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 35.3. The average price that BAYN.DE shares were previous bought at was EUR 25.5367. The current market price is 38.2% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 81,769 (USD $96,016) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 108.5 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 108.5. The average price that BIM.PA shares were previous bought at was EUR 118.807. The current market price is -8.7% lower than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| CAMX.ST - | HOLD | 0 @ SEK 54.4072 | SEK 0 | The current share valuation price of CAMX.ST based on adjusted close was SEK 54.4072. The average price that CAMX.ST shares were previous bought at was SEK 54.4174. The current market price is 0.0% lower than average price they were purchased at. The value of the holding in CAMX.ST has increased by SEK 15,450 (USD $1,662) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 72.7319 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 72.7319. The average price that COLO-B.CO shares were previous bought at was DKK 85.9966. The current market price is -15.4% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 49,114 (USD $7,720) compared to the previous valuation of |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.77314 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.77314. The average price that CTEC.L shares were previous bought at was GBP 3.2533. The current market price is -14.8% lower than average price they were purchased at. The value of the holding in CTEC.L has increased by GBP 8,627 (USD $11,538) compared to the previous valuation of ConvaTec Group PLC however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ABVX.PA - Abivax SA | HOLD | 0 @ EUR 97.6 | EUR 0 | The current share valuation price of ABVX.PA based on adjusted close was EUR 97.6. The average price that ABVX.PA shares were previous bought at was EUR 96.6. The current market price is 1.0% higher than average price they were purchased at. The value of the holding in ABVX.PA has increased by EUR 64,297 (USD $75,500) compared to the previous valuation of Abivax SA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 63.74 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 63.74. The average price that DIA.MI shares were previous bought at was EUR 94.7431. The current market price is -32.7% lower than average price they were purchased at. The value of the holding in DIA.MI has fallen by EUR 2,883 (USD $3,385) compared to the previous valuation of DiaSorin SpA |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 203.7 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 203.7. The average price that DIM.PA shares were previous bought at was EUR 198.697. The current market price is 2.5% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 2,357 (USD $2,768) compared to the previous valuation of Sartorius Stedim Biotech |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 276.3 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 276.3. The average price that EL.PA shares were previous bought at was EUR 249.493. The current market price is 10.7% higher than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 347,310 (USD $407,823) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 61.66 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 61.66. The average price that ERF.PA shares were previous bought at was EUR 57.9306. The current market price is 6.4% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 121,339 (USD $142,480) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 40.28 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 40.28. The average price that FME.DE shares were previous bought at was EUR 47.7662. The current market price is -15.7% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 1,793 (USD $2,105) compared to the previous valuation of Fresenius Medical Care AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 47.92 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 47.92. The average price that FRE.DE shares were previous bought at was EUR 42.5864. The current market price is 12.5% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 24,618 (USD $28,907) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 176.99 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 176.99. The average price that GALD.SW shares were previous bought at was CHF 119.446. The current market price is 48.2% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 185,778 (USD $233,624) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| GETI-B.ST - | HOLD | 0 @ SEK 19.4489 | SEK 0 | The current share valuation price of GETI-B.ST based on adjusted close was SEK 19.4489. The average price that GETI-B.ST shares were previous bought at was SEK 17.2977. The current market price is 12.4% higher than average price they were purchased at. The value of the holding in GETI-B.ST has fallen by SEK 8,794 (USD $946) compared to the previous valuation of |
| GMAB.CO - | HOLD | 0 @ DKK 268.227 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 268.227. The average price that GMAB.CO shares were previous bought at was DKK 187.649. The current market price is 42.9% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 54,576 (USD $8,578) compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.795 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.795. The average price that GRF.MC shares were previous bought at was EUR 10.3959. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 15,094 (USD $17,724) compared to the previous valuation of Grifols SA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 20.7015 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 20.7015. The average price that GSK.L shares were previous bought at was GBP 17.0544. The current market price is 21.4% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 346,687 (USD $463,680) compared to the previous valuation of GlaxoSmithKline PLC |
| HIK.L - | HOLD | 0 @ GBP 17.2465 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 17.2465. The average price that HIK.L shares were previous bought at was GBP 23.8802. The current market price is -27.8% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 852 (USD $1,140) compared to the previous valuation of |